SHANGHAI HILE BIO-TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 603718 for the last quarter is 69.51 M CNY, and it's 53.12% higher compared to the previous quarter. The net income of Q1 24 is -3.72 M CNY.